Search bioRxiv⌕ Search

Biology subjects

Starczak, M.

Publications and source records attributed to Starczak, M..

3 recordsLinked to original sources

Loss of TET2 activity limits the ability of vitamin C to activate DNA demethylation in human HAP1 cells

BackgroundThe TET family of proteins - TET1, TET2, and TET3 - are -KG and Fe2+ dependent dioxygenases that play crucial roles in active DNA demethylation and the deposition of epigenetic marks such as 5-hydroxymethylcytosine, 5-formylcytosine, and 5-carboxycytosine. TET proteins can also oxidize thymine to 5-hydroxymethyl uracil - a modification whose role is still poorly understood. TET proteins add a new layer of information in regulating gene expression, cellular development, and lineage specification. Dysregulation of TET activity is implicated in various cancers, especially in hematological malignancies, where TET2 loss-of-function mutations are prevalent. TET2s role in hematopoiesis is critical, as its knockdown skews progenitor differentiation toward the myeloid lineage and drives carcinogenesis. Therefore, restoring the lost activity of TET proteins is often proposed as an important component of cancer treatment. This study explores the distinct contributions of TET paralogs in generating active demethylation products in malignant cells. It examines whether vitamin C, a known cofactor of many dioxygenases, can compensate for the loss of specific TET paralogs. We applied a highly sensitive and specific methodology (2D-UPLC-MS/MS) to assess TET activity in the HAP1 cell line with single and double TET functional knockouts and in cells with the activity of all TET proteins impaired. ResultsOur findings reveal that TET2 is essential for all steps of iterative oxidation, and its loss has the most significant effect on 5-hydroxymethylcytosine and 5-formylcytosine levels. Vitamin C enhances TET activity and increases the levels of these oxidation products. However, its effect in TET2 knockout cells is limited; Vitamin C increased cytosine modification levels in TET2KO cells, but not to the extent observed in treated wild-type cells, indicating incomplete compensation for TET2 loss. ConclusionsOur results demonstrated that each TET protein has a distinct, separate contribution to generating active demethylation products. The absence of individual TET paralog is linked with the specific pattern of active demethylation products in DNA, which is preserved after vitamin C treatment. Therefore, the deletion of one of the TET enzymes cannot be compensated for by the increased activity of the other TET family members, highlighting the unique roles of each TET paralog in epigenetic regulation.

cell biology↗

APOBEC3A deaminase catalyzes site-specific editing of transfer RNAs

APOBEC3A is a cytidine deaminase that plays a crucial role in innate immunity; however, it can also drive oncogenesis when dysregulated. While its DNA editing activity is well-studied, the impact of APOBEC3A on RNA has only recently gained attention. Previous studies revealed that APOBEC3A deaminates mRNA stem-loop structures, however, its activity on other RNA classes remains unexplored. Given its likely evolutionary origin from tRNA adenosine deaminases and the prevalence of stem-loop structures in tRNA, we investigated APOBEC3As activity on tRNAs. We found that in vitro APOBEC3A efficiently deaminates a large spectrum of tRNA isoacceptors, primarily at anticodon positions. To assess whether the editing sites identified in vitro can be detected in tumor tissues, we analyzed data from The Cancer Genome Atlas. We identified six editing sites present in numerous patient samples. Our results point to a possible impact of APOBEC3A on tRNA decoding capacity, with potential relevance to mistranslation and cancer development.

molecular biology↗

Distinct Pattern Of Epigenetic DNA Modification In Leukocytes From Patients With Colorectal Carcinoma And Individuals With Precancerous Conditions, Benign Adenoma And Inflammatory Bowel Disease; A Link To Oxidative Stress

A characteristic feature of malignant cells, including colorectal cancer cells, is a profound decrease in level of 5-hydroxymethylcytosine, product of 5-methylcytosine oxidation by TET enzymes. This study included four groups of subjects: healthy controls, and patients with inflammatory bowel disease (IBD), benign polyps and colorectal cancer. Patients from all groups presented with significantly lower levels of 5-methylcytosine and 5-hydroxymethylcytosine than the controls. A similar tendency was also observed for 5-hydroxymethyluracil level. Patients with IBD showed the highest levels of 5-formylcytosine and 8-oxo-7,8-dihydro-2-deoxyguanosine of all study subjects, and individuals with colorectal cancer presented with the lowest concentrations of vitamin C and A. Expressions of TET1 and TET2 turned out to be the highest in IBD group. To the best of our knowledge, this is the first study to show that healthy subjects, individuals with precancerous conditions and colorectal cancerpatients present with distinct specific patterns of epigenetic modifications in leukocyte DNA.

cancer biology↗